Satsuma Pharmaceuticals Inc. sell klostergang
Start price
11.09.20
/
50%
€4.30
Target price
04.11.21
€2.00
Performance (%)
16.74%
End price
17.06.21
€5.02
Summary
This prediction ended on 17.06.21 with a price of €5.02. The SELL prediction by klostergang finished with a performance of 16.74%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Satsuma Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
According to klostergang what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Risky balance sheet
ROE lower than 10% per year
No uniques
Growths much slower than the competition
Higher risks for its business
Nicheplayer
Little known brand